A Cheshire mother’s battle with liver failure and brain injury highlights hidden risks of a popular stress‑relief supplement.
Lois Kinder, a 44-year-old mother of two living in Lymm, Cheshire, was a regular user and promoter of ashwagandha gummies for about a year. The herbal product, marketed as a natural adaptogen to ease everyday stress, had become a staple of her TikTok affiliate work.
In July, the routine that once seemed harmless spiraled into a medical emergency that left her with irreversible brain injury.
The first warning signs appeared when Lois noticed her skin and eyes turning yellow—a classic sign of jaundice. Concerned, she visited her general practitioner, who ordered blood tests and a liver scan.
Within days, her 19-year-old daughter, Imogen, found her mother unconscious on the family sofa. Paramedics revived her, but she was confused and could not recognize her children. She was transferred to Warrington Hospital, where clinicians confirmed acute liver failure.
Timeline of the medical crisis
Following the diagnosis, doctors placed Lois in a medically induced coma and, three days later, moved her to the Liver Intensive Care Unit at Queen Elizabeth Hospital in Birmingham. She was added to the UK’s super-urgent transplant list. After several unsuitable donor offers, a matching liver became available on July 22. The transplant operation, however, was fraught with complications: a blood clot blocked the main pulmonary artery, causing three cardiac arrests. The resulting oxygen deprivation inflicted severe damage on her brain.
Despite the odds, Lois survived the surgery and emerged from the coma on August 13. The family was told repeatedly that she might not pull through, yet she defied those grim predictions. Nevertheless, the period without oxygen left her with permanent neurological deficits. Today, she remains in critical care at Queen Elizabeth Hospital, capable of only minimal finger and toe movements and occasional words.
Medical experts weigh in on ashwagandha’s risks
While ashwagandha is praised for its adaptogenic properties—helping the body cope with stress—researchers acknowledge that high doses can be hepatotoxic. Dipa Kamadar, a pharmacy specialist at Kingston University, explained that severe liver injury linked to the herb is rare but documented. “Although uncommon, there have been reports of liver problems, including acute failure, associated with ashwagandha use,” she said in a report for The Conversation. The herb may also stimulate the immune system, potentially aggravating autoimmune conditions.
Doctors treating Lois identified the daily intake of two ashwagandha gummies as a possible trigger for her liver collapse. They cited a known dataset of roughly 70 similar cases worldwide. Though causality is still under investigation, the medical team regards the supplement as the primary suspect.
Broader implications and warning messages
Lois’s case arrives at a time when online platforms are saturated with wellness products promising quick relief. Brands such as Lemme, co-founded by celebrity Kourtney Kardashian, market “clinically tested” gummy formulations of ashwagandha, claiming reduced stress and balanced cortisol levels. However, the British Food Standards Agency (FSA) has issued a fresh advisory urging shoppers to verify the reputation of sellers, especially on marketplaces where product provenance can be opaque.
Ollie Kinder, Lois’s husband and a cabin-crew manager, has launched a crowdfunding campaign to secure a suitable home for his wife’s long-term care. He emphasizes that the tragedy underscores the need for stricter scrutiny of supplements sold online. “I want to spread awareness and warn people that even if a product seems safe, serious health consequences can follow,” he said.
The medical team plans to publish a detailed case study, hoping the experience will inform clinicians worldwide about the challenges of managing acute liver failure linked to dietary supplements and the neurological sequelae of intra-operative hypoxia.
As the family navigates daily rehabilitation, uncertainty looms over Lois’s future mobility and independence. Her husband summed up the situation: “We don’t know if she will walk again, regain full use of her body, or what level of care she will need in the future.” The story serves as a stark reminder that natural does not always equal harmless, especially when products are consumed in unregulated, high-dose formats.
